Comparative Effectiveness of Glucagon-Like Peptide-1 Receptor Agonists, Sodium-Glucose Cotransporter 2 Inhibitors, Dipeptidyl Peptidase-4 Inhibitors, and Sulfonylureas for Sight-Threatening Diabetic Retinopathy.
第一作者:
Andrew J,Barkmeier
第一单位:
Department of Ophthalmology, Mayo Clinic, Rochester, Minnesota. Electronic address: barkmeier.andrew@mayo.edu.
作者:
医学主题词
女(雌)性(Female);人类(Humans);男(雄)性(Male);血糖(Blood Glucose);糖尿病, 2型(Diabetes Mellitus, Type 2);糖尿病视网膜病变(Diabetic Retinopathy);二肽基肽酶Ⅳ抑制剂(Dipeptidyl-Peptidase IV Inhibitors);随访研究(Follow-Up Studies);降血糖药(Hypoglycemic Agents);回顾性研究(Retrospective Studies);磺酰脲化合物(Sulfonylurea Compounds);治疗结果(Treatment Outcome);美国(United States);成年人(Adult)
DOI
10.1016/j.oret.2024.05.003
PMID
38735641
发布时间
2025-07-10
- 浏览0
Ophthalmology. Retina
2024年8卷10期
943-952页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文


换一批



